Frontlight ResearchEarly access
Trial site
Childrens Hospital Boston, Dana-Farber Cancer Institute.
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers6 trials
- Neuroblastoma6 trials
- Phase
- Phase 14 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- New Approaches to Neuroblastoma Therapy Consortium6 trials
Running trials
Not yet recruiting
NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
Active, not recruiting
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Active, not recruiting
Active, not recruiting
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Neuroblastoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026